DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0) (BioCAD00000021158)

blood all tissues

Metabolite Card

Formula: C41H68O5 (640.5066)
SMILES: [H][C@](CO)(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCC\C=C/C\C=C/C\C=C/CCCCCCCC

Synonyms [en]

DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0); 1-g-Linolenoyl-2-meadoyl-sn-glycerol; (2S)-1-hydroxy-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propan-2-yl (5Z,8Z,11Z)-icosa-5,8,11-trienoate; DAG(38:6); Diacylglycerol; DAG(18:3/20:3)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021158). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of mead acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the mead acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

  • CAS Registry Number:
  • PubChem CID: 53478126
  • ChEBI: 89162
  • HMDB: HMDB0007284
  • LipidMaps:
  • KEGG:
  • BioCyc:
  • NCBI MeSH:
  • Wikipedia:
Other DBLinks
  • PubChem: 53478126
  • ChEBI: ChEBI:89162
  • HMDB: HMDB0007284
  • HMDB: HMDB07284
  • Metlin: METLIN_58836
  • Coconut NaturalProduct: CNP0084509.1

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0066966 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))
PathBank:SMP0066970 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:0)
PathBank:SMP0066974 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0066978 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/24:0)
PathBank:SMP0075716 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0075720 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0075724 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0075728 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/24:0)
PathBank:SMP0086305 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0086309 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0090989 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0090993 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0090997 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0091001 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/24:0)
PathBank:SMP0100242 PathBank:SMP0100242
PathBank:SMP0024559 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0024563 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0066965 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
PathBank:SMP0066969 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0066973 De Novo Triacylglycerol Biosynthesis TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
View All Pathways